Test bank For Pharmacotherapeutics for Advanced Practice: A practical Approach 5th Edition by Virginia P. Arcangelo and Peterson | All Chapters 1-56

Test bank For Pharmacotherapeutics for Advanced Practice: A practical Approach 5th Edition by Virginia P. Arcangelo and Peterson | All Chapters 1-56. Chapter 1: Issues for the Practitioner in Drug Therapy Chapter 2: Pharmacokinetic Basis of Therapeutics and Pharmacodynamic Principles Chapter 3: Impact of Drug Interactions and Adverse Events on Therapeutics Chapter 4: Principles of Pharmacotherapy in Pediatrics, Pregnancy and Lactation Chapter 5: Pharmacotherapy Principles in Older Adults Chapter 6: Principles of Antimicrobial Therapy Chapter 7: Pharmacogenomics Chapter 8: The Economics of Pharmacotherapeutics Chapter 9: Principles of Pharmacology in Pain Management Chapter 10: Pain Management in Opioid Use Disorder (OUD) Patients Chapter 11: Cannabis and Pain Management Chapter 12: Dermatitis Chapter 13: Bacterial, Fungal, and Viral Infections of the Skin Chapter 14: Psoriasis Chapter 15: Acne Vulgaris and Rosacea Chapter 16: Ophthalmic Disorders Chapter 17: Otitis Media and Otitis Externa Chapter 18: Hypertension Chapter 19: Hyperlipidemia Chapter 20: Chronic Stable Angina and Myocardial Infarction Chapter 21: Heart Failure Chapter 22: Arrhythmias Chapter 23: Respiratory Infections Chapter 24: Asthma and Chronic Obstructive Pulmonary Disease Chapter 25: Gastric, Functional and Inflammatory Bowel Disorders Chapter 26: Gastroesophageal Reflux Disease and Peptic Ulcer Disease Chapter 27: Liver Diseases Chapter 28: Urinary Tract Infection Chapter 29: Prostatic Disorders and Erectile Dysfunction Chapter 30: Overactive Bladder Chapter 31: Sexually Transmitted Infections Chapter 32: Osteoarthritis and Gout Chapter 33: Osteoporosis Chapter 34: Rheumatoid Arthritis Chapter 35: Headaches Chapter 36: Seizure Disorders Chapter 37: Alzheimer’s Disease Chapter 38: Parkinson Disease Chapter 39: Major Depressive Disorder and Bipolar Disorders Chapter 40: Anxiety Disorders Chapter 41: Sleep Disorders Chapter 42: Attention Deficit Hyperactivity Disorder Chapter 43: Substance Use Disorders Chapter 44: Diabetes Mellitus Chapter 45: Thyroid and Parathyroid Disorders Chapter 46: Allergies and Allergic Reactions Chapter 47: Human Immunodeficiency Virus Chapter 48: Organ Transplantation Chapter 49: Pharmacotherapy for Select Thromboembolic Disorders Chapter 50: Anemias Chapter 51: Immunizations Chapter 52: Smoking Cessation Chapter 53: Weight Loss Chapter 54: Contraception Chapter 55: Menopause Chapter 56: Vaginitis Chapter 1 Issues for the Practitioner in Drug Therapy MULTIPLE CHOICE 1. Nurse practitioner prescriptive authority is regulated by: A. The National Council of State Boards of Nursing B. The U.S. Drug Enforcement Administration C. The State Board of Nursing for each state D. The State Board of Pharmacy Answer: C PTS: 1 2. Physician Assistant (PA) prescriptive authority is regulated by: A. The National Council of State Boards of Nursing B. The U.S. Drug Enforcement Administration C. The State Board of Nursing D. The State Board of Medical Examiners Answer: D PTS: 1 3. Nurse practitioner practice may thrive under health-care reform due to: A. The demonstrated ability of nurse practitioners to control costs and improve patient outcomes B. The fact that nurse practitioners will be able to practice independently C. The fact that nurse practitioners will have full reimbursement under health-care reform D. The ability to shift accountability for Medicaid to the state level Answer: A PTS: 1 4. Clinical judgment in prescribing includes: A. Factoring in the cost to the patient of the medication prescribed B. Always prescribing the newest medication available for the disease process C. Handing out drug samples to poor patients D. Prescribing all generic medications to cut costs Answer: A PTS: 1 5. Criteria for choosing an effective drug for a disorder include: A. Asking the patient what drug they think would work best for them B. Consulting nationally recognized guidelines for disease management C. Prescribing medications that are available as samples before writing a prescription D. Following U.S. Drug Enforcement Administration (DEA) guidelines for prescribing Answer: B PTS: 1 Chapter 2.Pharmacokinetic Basis of Therapeutics and Pharmacodynamic MULTIPLE CHOICE 1. A patient’s nutritional intake and lab work reflects hypoalbuminemia. This is critical to prescribing because: A. Distribution of drugs to target tissue may be affected B. The solubility of the drug will not match the site of absorption C. There will be less free drug available to generate an effect D. Drugs bound to albumin are readily excreted by the kidney Answer: A PTS: 1 2. Drugs that have a significant first-pass effect: A. Must be given by the enteral (oral) route only B. Bypass the hepatic circulation C. Are rapidly metabolized by the liver and may have little if any desired action D. Are converted by the liver to more active and fat-soluble forms Answer: C PTS: 1 3. The route of excretion of a volatile drug will likely be: A. The kidneys B. The lungs C. The bile and feces D. The skin Answer: B PTS: 1 4. Phenytoin requires a trough level be drawn. Peak and trough levels are done: A. When the drug has a wide therapeutic range B. When the drug will be administered for a short time only C. When there is a high correlation between the dose and saturation of receptor sites D. To determine if a drug is in the therapeutic range Answer: D PTS: 1 5. A laboratory result indicates the peak level for a drug is above the minimum toxic concentration. This means that the: A. Concentration will produce therapeutic effects B. Concentration will produce an adverse response C. Time between doses must be shortened D. Duration of action of the drug is too long